newsfilter
← Latest News
GlobeNewswire·

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

LEIDEN, Netherlands and CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) ("ProQR"), a clinical-stage biotechnology company dedicated to changing lives through